Research on GLP-1 receptor agonists is exploring their potential as therapeutics beyond diabetes and obesity, with possible applications in treating steatotic liver disease and other conditions. These drugs may have multifunctional benefits for metabolic health, with some studies examining their effects on cardiovascular health and potential uses in multi-organ therapy. The field is expected to see continued development, with trends including expanded uses and oral options for GLP-1 treatments.